Solid Biosciences Inc.
SLDB
$5.10
-$0.12-2.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.87% | 1.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.27% | 4.10% | |||
| Operating Income | -15.27% | -4.10% | |||
| Income Before Tax | -15.95% | -0.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -15.95% | -0.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.95% | -0.50% | |||
| EBIT | -15.27% | -4.10% | |||
| EBITDA | -15.43% | -4.19% | |||
| EPS Basic | -15.59% | 29.17% | |||
| Normalized Basic EPS | -15.60% | 29.18% | |||
| EPS Diluted | -15.59% | 29.17% | |||
| Normalized Diluted EPS | -15.60% | 29.18% | |||
| Average Basic Shares Outstanding | 0.29% | 41.90% | |||
| Average Diluted Shares Outstanding | 0.29% | 41.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||